NOVERA COMPOUNDS

Cagrilintide 10mg

10% off, code: PEPTEN
Purity Guarantee

Cagrilintide 10mg

Sign in to view pricing and purchase this product.

Log In Sign Up
Quantity Discount (%) Price
1 - 5 — $129.00
6 - 10 9.3 % $117.00
11 - 20 17.83 % $106.00
21+ 25.58 % $96.00

Why choose Novera Compounds peptides

Research-grade Quality

Every compound is manufactured to research-grade standards and intended strictly for laboratory and research use. Consistent quality you can build a reproducible protocol around.

Documented and traceable

  • Batch number on every vial

  • Published Certificates of Analysis

  • Purity verified by third-party testing

Handled and shipped with care

Temperature-sensitive compounds are stored and shipped under controlled conditions, so material arrives in the state your research requires. Expert support on hand at every step.

About the product

Cagrilintide (10mg) is a synthetic peptide analog designed to mimic certain structural and signaling properties of the naturally occurring hormone amylin. This peptide belongs to a class of engineered peptides studied for their roles in metabolic regulation and endocrine signaling. It has a molecular weight of 4,409 g/mol and is produced through controlled peptide synthesis to achieve high analytical purity suitable for laboratory use.

In research settings, Cagrilintide is typically supplied as a lyophilized powder in a sterile 10 mg vial, enabling precise preparation according to experimental protocols. Current research explores how amylin-related peptide analogs interact with biological systems involved in energy balance, cellular communication, and metabolic signaling pathways.

Cagrilintide (10mg) Key Features & Specs

  • Subcategory: Weight Loss & Metabolic Peptides
  • Strength: 10 mg
  • CAS: 1415456-99-3
  • Chemical Formula: C₁₉₄H₃₁₂N₅₄O₅₉S₂
  • Molecular Weight: 4409 g/mol
  • Peptide Sequence: XKCNTATCATQRLAEFLRHSSNNFGPILPPTNVGSNTP
  • Synonyms: NN0174-0833, AM833, EX-A10092

For laboratory research use only.

Cagrilintide (10mg) Research Uses

Cagrilintide metabolic research focuses on understanding how amylin-related peptide analogs modulate metabolic signaling pathways. Researchers often study this compound in models that evaluate energy regulation, appetite-related signaling, and endocrine communication.

Cagrilintide has been studied in experimental systems to examine how peptide hormones interact with metabolic tissues and the regulatory pathways involved in glucose balance and energy utilization. These investigations are conducted in controlled laboratory models.

Ongoing research examines how peptide-based signaling may affect communication between metabolic tissues, including the pancreas, gastrointestinal tract, and central regulatory systems.

Cagrilintide (10mg) Insights & Observed Findings

Experimental investigations involving Cagrilintide commonly evaluate peptide exposure levels in controlled laboratory models. These studies are designed to observe measurable metabolic signaling responses under specific research conditions.

In metabolic research, investigators examine concentration ranges used in preclinical studies to evaluate markers associated with metabolic activity, hormonal signaling, and cellular communication.

Published observations describe experimental environments where researchers measure changes in laboratory indicators, such as metabolic biomarkers, gene expression signals, and peptide-mediated cellular responses.

Cagrilintide (10mg) Handling & Storage

Cagrilintide is supplied as a lyophilized peptide powder for laboratory preparation. Recommended handling practices include:

  • Storage: Store at –20°C in a controlled laboratory freezer.
  • Protection: Protect the peptide from light, heat, and moisture.
  • Pre-opening: Allow the vial to reach room temperature before opening to minimize condensation.
  • Reconstitution: Reconstitute using sterile laboratory-grade solvent according to experimental protocols.
  • Post-reconstitution: Use prepared solution promptly according to experimental protocols.

Proper storage and handling help preserve peptide integrity during research procedures.

Compliance Notice: This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.

References

  1. D'Ascanio AM, Mullally JA, Frishman WH. Cagrilintide: A Long-Acting Amylin Analog for the Treatment of Obesity. Cardiol Rev. 2024;32(1):83-90. doi:10.1097/CRD.0000000000000513
  2. Lau DCW, Erichsen L, Francisco AM, et al. Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial. Lancet. 2021;398(10317):2160-2172. doi:10.1016/S0140-6736(21)01751-7
  3. Dutta D, Nagendra L, Harish BG, et al. Efficacy and Safety of Cagrilintide Alone and in Combination with Semaglutide (Cagrisema) as Anti-Obesity Medications: A Systematic Review and Meta-Analysis. Indian J Endocrinol Metab. 2024;28(5):436-444. doi:10.4103/ijem.ijem_45_24
  4. Kruse T, Hansen JL, Dahl K, et al. Development of Cagrilintide, a Long-Acting Amylin Analogue. J Med Chem. 2021;64(15):11183-11194. doi:10.1021/acs.jmedchem.1c00565